The Discounted Cash Flow (DCF) valuation of Yabao Pharmaceutical Group Co Ltd (600351.SS) is 5.19 CNY. With the latest stock price at 6.28 CNY, the upside of Yabao Pharmaceutical Group Co Ltd based on DCF is -17.3%.
Based on the latest price of 6.28 CNY and our DCF valuation, Yabao Pharmaceutical Group Co Ltd (600351.SS) is a sell. selling 600351.SS stocks now will result in a potential gain of 17.3%.
| Range | Selected | |
| WACC / Discount Rate | 8.2% - 10.5% | 9.4% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 4.13 - 7.47 | 5.19 |
| Upside | -34.2% - 18.9% | -17.3% |